Controlling giardiosis

US8440612B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Gisela Greif · Bad Honnef, DE
• Achim Harder · Leverkusen, DE
• Thomas Bach · Wuppertal, DE
• Gabriele Petry · Krefeld, DE
• Eva-Maria Kruedewagen · Monheim, DE

Key dates

• Filing date: Jun 20, 2009
• Grant date: May 14, 2013
• Expiry date: Sep 14, 2029

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of nifurtimox for the treatment of giardiosis, in particular in dogs and cats.